Sustained Virologic Response: Effect of Cirrhosis

SVR (%)

61%

65%

50%

n=436

n=321

n=115

All patients

Non-cirrhotics

Cirrhotics

Treatment: PEGASYSÆ + RBV 1000/1200 mg for 48 weeks

Previous slide Next slide Back to first slide View graphic version

Notes:

No efficacy benefit seen in Non-1 when increase treatment duration from 24 to 48 wks and/or when increase RBV from the lower, 800mg dose to the standard dose.

Due to time will not show split for viral titre but will say no difference